中华医学杂志（英文版）2025，Vol.138Issue(4)：478-480,3.DOI:10.1097/CM9.0000000000003385
Potential utility of albumin-bilirubin and body mass index-based logistic model to predict survival outcome in non-small cell lung cancer with liver metastasis treated with immune checkpoint inhibitors
Potential utility of albumin-bilirubin and body mass index-based logistic model to predict survival outcome in non-small cell lung cancer with liver metastasis treated with immune checkpoint inhibitors
Lianxi Song 1Haoyue Qin 2Huan Yan 2Xing Zhang 2Fan Tong 3Ruiguang Zhang 4Zhaoyi Liu 5Lin Zhang 6Xiaorong Dong 4Ting Li 5Chao Fang 7Qinqin Xu 8Xue Chen 7Jun Deng 7Jing Wang 7Nong Yang 2Liang Zeng 9Yongchang Zhang 10Ting Zhong 11Wenhuan Guo 12Shaoding Lin 3Wenjuan Jiang 9Zhan Wang 9Li Deng 9Zhe Huang9
作者信息
- 1. Department of Medical Oncology,Lung Cancer and Gastrointestinal Unit,Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine,Central South University,Changsha,Hunan 410013,China||Graduate Collaborative Training Base of Hunan Cancer Hospital,Hengyang Medical School,University of South China,Hengyang,Hunan 421001,China||Department of Medical Oncology,Yiyang Central Hospital,Yiyang,Hunan 413000,China
- 2. Department of Medical Oncology,Lung Cancer and Gastrointestinal Unit,Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine,Central South University,Changsha,Hunan 410013,China||Graduate Collaborative Training Base of Hunan Cancer Hospital,Hengyang Medical School,University of South China,Hengyang,Hunan 421001,China
- 3. Department of Medical Oncology,The First Affiliated Hospital of Hunan University of Medicine,Huaihua,Hunan 418000,China
- 4. Cancer Center,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,Hubei 430022,China
- 5. Department of Medical Oncology,The Affiliated Cancer Hospital of Xiangya School of Medicine,Central South University/Hunan Cancer Hospital,Changsha,Hunan 410008,China
- 6. Department of Radiotherapy,The Affiliated Cancer Hospital of Xiangya School of Medicine,Central South University/Hunan Cancer Hospital,Changsha,Hunan 410008,China
- 7. Early Clinical Trial Center,Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine,Central South University,Changsha,Hunan 410013,China
- 8. Department of Medical Oncology,Qinghai Provincial People's Hospital,Xining,Qinghai 810000,China
- 9. Department of Medical Oncology,Lung Cancer and Gastrointestinal Unit,Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine,Central South University,Changsha,Hunan 410013,China
- 10. Department of Medical Oncology,Lung Cancer and Gastrointestinal Unit,Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine,Central South University,Changsha,Hunan 410013,China||Graduate Collaborative Training Base of Hunan Cancer Hospital,Hengyang Medical School,University of South China,Hengyang,Hunan 421001,China||Early Clinical Trial Center,Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine,Central South University,Changsha,Hunan 410013,China
- 11. Department of Medical Oncology,Yiyang Central Hospital,Yiyang,Hunan 413000,China
- 12. Department of Pathology,Ninth People's Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 20025,China
- 折叠
引用本文复制引用
Lianxi Song,Haoyue Qin,Huan Yan,Xing Zhang,Fan Tong,Ruiguang Zhang,Zhaoyi Liu,Lin Zhang,Xiaorong Dong,Ting Li,Chao Fang,Qinqin Xu,Xue Chen,Jun Deng,Jing Wang,Nong Yang,Liang Zeng,Yongchang Zhang,Ting Zhong,Wenhuan Guo,Shaoding Lin,Wenjuan Jiang,Zhan Wang,Li Deng,Zhe Huang..Potential utility of albumin-bilirubin and body mass index-based logistic model to predict survival outcome in non-small cell lung cancer with liver metastasis treated with immune checkpoint inhibitors[J].中华医学杂志（英文版）,2025,138(4):478-480,3.基金项目
This work was financially supported by the National Natural Science Foundation of China(Nos.82222048 and 82003206)and the Natural Science Foundation of Hunan Province(No.2021RC3118). （Nos.82222048 and 82003206）
